These results, along with a prior report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,2 guidance the thought of focusing on ACKR3 as a novel technique to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-connected Diseases. We independently investigate, review, https://yurir617gxn2.mdkblog.com/profile